QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
A | ||
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
one-half of one redeemable warrant |
Large accelerated filer | ☐ |
Accelerated filer | ☐ | |||
Non-accelerated filer |
☒ |
Smaller reporting company | ||||
Emerging growth company |
Page |
||||
1 | ||||
2 | ||||
3 | ||||
4 | ||||
5 | ||||
18 | ||||
2 1 |
||||
21 | ||||
21 | ||||
21 | ||||
21 | ||||
22 | ||||
22 | ||||
22 | ||||
22 | ||||
23 |
Item 1. |
Condensed Financial Statements. |
June 30, 2021 |
December 31, 2020 |
|||||||
(Unaudited) | ||||||||
ASSETS |
||||||||
Current assets |
||||||||
Cash |
$ | $ | ||||||
Prepaid expenses |
||||||||
|
|
|
|
|||||
Total Current Assets |
||||||||
Deferred offering costs |
||||||||
Investment held in Trust Account |
||||||||
|
|
|
|
|||||
TOTAL ASSETS |
$ |
$ |
||||||
|
|
|
|
|||||
LIABILITIES AND SHAREHOLDERS’ EQUITY |
||||||||
Current liabilities |
||||||||
Accrued expenses |
$ | $ | ||||||
Accrued offering costs |
||||||||
Due to related party |
||||||||
Promissory note - related party |
||||||||
|
|
|
|
|||||
Total Current Liabilities |
||||||||
Forward Purchase Agreement (FPA) liability |
||||||||
Warrant liabilities |
||||||||
Deferred underwriting fee payable |
||||||||
|
|
|
|
|||||
Total Liabilities |
||||||||
|
|
|
|
|||||
Commitments and Contingencies (Note 6) |
||||||||
Class A ordinary shares subject to possible redemption |
||||||||
Shareholders’ Equity |
||||||||
Preference shares, $ |
||||||||
Class A ordinary shares, $ |
||||||||
Class B ordinary shares, $ at June 30, 2021 and December 31, 2020 |
||||||||
Additional paid-in capital |
||||||||
Retained earnings (Accumulated deficit) |
( |
) |
( |
) | ||||
|
|
|
|
|||||
Total Shareholders’ Equity |
||||||||
|
|
|
|
|||||
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY |
$ |
$ |
||||||
|
|
|
|
For the three months ended June 30, 2021 |
For the six months ended June 30, 2021 |
|||||||
General and administrative expenses |
$ | ( |
) | $ | ||||
|
|
|
|
|||||
Loss from operations |
( |
) | ||||||
|
|
|
|
|||||
Other income (expense) |
||||||||
Change in fair value of FPA |
( |
) | ( |
) | ||||
Change in fair value of warrant liabilities |
( |
) | ||||||
Offering costs allocable to warrants |
( |
) | ||||||
Interest earned on investment held in Trust Account |
||||||||
|
|
|
|
|||||
Other income (expense), net |
( |
) | ||||||
|
|
|
|
|||||
Net income (loss) |
$ | ( |
) | $ | ||||
|
|
|
|
|||||
Weighted average shares outstanding, Class A redeemable ordinary shares |
||||||||
|
|
|
|
|||||
Basic and diluted net income per share, Class A redeemable ordinary shares |
$ | $ | ||||||
|
|
|
|
|||||
Weighted average shares outstanding, Class B non-redeemable ordinary shares |
||||||||
|
|
|
|
|||||
Basic and diluted net income (loss) per share, Class B non-redeemable ordinary shares |
$ | ( |
) | $ | ||||
|
|
|
|
Class A |
Class B |
Retained Earnings |
||||||||||||||||||||||||||
Ordinary Share |
Ordinary Share |
Additional |
(Accumulated |
Shareholders’ |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Paid-In Capital |
Deficit) |
Equity |
||||||||||||||||||||||
Balance as of January 1, 2021 |
$ | $ | $ | $ | ( |
) | $ | |||||||||||||||||||||
Sale of |
||||||||||||||||||||||||||||
Class A ordinary shares subject to redemption |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||
Net Income |
— | — | ||||||||||||||||||||||||||
Balance as of March 31, 2021 |
$ | $ | $ | $ | $ | |||||||||||||||||||||||
Class A ordinary shares subject to redemption |
||||||||||||||||||||||||||||
Net loss |
— | ( |
) | ( |
) | |||||||||||||||||||||||
Balance as of June 30, 2021 |
$ | $ | $ | $ | ( |
) | $ | |||||||||||||||||||||
Cash Flows from Operating Activities: |
||||
Net income |
$ | |||
Adjustments to reconcile net income to net cash used in operating activities: |
||||
Interest earned on investment held in Trust Account |
( |
) | ||
Change in fair value of FPA |
||||
Change in fair value of warrant liabilities |
( |
) | ||
Offering costs incurred in connection with Initial Public Offering |
||||
Changes in operating assets and liabilities: |
||||
Prepaid expenses |
( |
) | ||
Accrued expenses |
||||
Accrued offering costs |
( |
) | ||
Due to related party |
||||
|
|
|||
Net cash used in operating activities |
( |
) | ||
|
|
|||
Cash Flows from Investing Activities: |
||||
Investment of cash into Trust Account |
( |
) | ||
|
|
|||
Net cash used in investing activities |
( |
) | ||
|
|
|||
Cash Flows from Financing Activities: |
||||
Proceeds from sale of Units, net of underwriting discounts paid |
||||
Proceeds from sale of Private Placement Warrants |
||||
Repayment of promissory note – related party |
( |
) | ||
Payment of offering costs |
( |
) | ||
|
|
|||
Net cash provided by financing activities |
||||
|
|
|||
Net Change in Cash |
||||
Cash – Beginning of period |
||||
|
|
|||
Cash – End of period |
$ | |||
|
|
|||
Non-Cash investing and financing activities: |
||||
|
|
|||
Offering costs paid through promissory note |
$ | |||
|
|
|||
Initial classification of Class A ordinary shares subject to possible redemption |
$ | |||
|
|
|||
Change in value of Class A ordinary shares subject to possible redemption |
$ | |||
|
|
|||
Deferred underwriting fee payable |
$ | |||
|
|
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||
2021 |
2021 |
|||||||
Redeemable Class A Ordinary Shares |
||||||||
Numerator: Earnings allocable to Redeemable Class A Ordinary Shares |
||||||||
Interest Income |
$ | $ | ||||||
|
|
|
|
|||||
Net Earnings |
$ | $ | ||||||
Denominator: Weighted Average Redeemable Class A Ordinary Shares |
||||||||
Redeemable Class A Ordinary Shares, Basic and Diluted |
||||||||
Income/Basic and Diluted Redeemable Class A Ordinary Shares |
$ | $ | ||||||
Non-Redeemable Class A and B Ordinary Shares |
||||||||
Numerator: Net Income (Loss) minus Redeemable Net Earnings |
||||||||
Net Income (Loss) |
$ | ( |
) | $ | ||||
Redeemable Net Earnings |
||||||||
|
|
|
|
|||||
Non-Redeemable Net Income (Loss) |
$ | ( |
) | $ | ||||
Denominator: Weighted Average Non-Redeemable Class A and B Ordinary Shares |
||||||||
Non-Redeemable Class A and B Ordinary Shares, Basic and Diluted (1) |
||||||||
Income (Loss ) Basic and Diluted Non-Redeemable Class A and B Ordinary Shares |
$ | ( |
) | $ |
• | in whole and not in part; |
• | at a price of $ |
• | upon not less than |
• | if, and only if, the last reported sale price of the Class A ordinary shares for any sub-divisions, share dividends, reorganizations, recapitalizations and the like). |
• | in whole and not in part; |
• | at $ |
• | if, and only if, the Reference Value equals or exceeds $ sub-divisions, share dividends, reorganizations, recapitalizations and the like); and |
• | if the Reference Value is less than $ sub-divisions, share dividends, reorganizations, recapitalizations and the like), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above. |
Level 1: |
Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. | |
Level 2: |
Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. | |
Level 3: |
Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. |
Description |
Level |
June 30, 2021 |
||||
Assets: |
||||||
Investments held in Trust Account – U.S. Treasury Securities Money Market Funds |
1 | $ | ||||
Liabilities: |
||||||
Warrant Liability – Public Warrants |
1 | $ | ||||
Warrant Liability – Private Placement Warrants |
3 | $ | ||||
FPA Liability |
3 | $ |
January 26, 2021 (Initial measurement) |
June 30, 2021 |
|||||||
Unit price |
$ | $ | ||||||
Term to initial business combination (in years) |
||||||||
Volatility |
% | % | ||||||
Risk-free rate |
% | % | ||||||
Dividend yield |
% | % |
Private Placement |
Public |
Total Warrant Liabilities |
||||||||||
Fair value as of January 1, 2021 |
$ |
— |
$ |
— |
$ |
— |
||||||
Initial measurement on January 26, 2021 |
||||||||||||
Transfer to Level 1 |
— |
( |
) |
( |
) | |||||||
Change in fair value |
( |
) |
— |
( |
) | |||||||
Fair value as of June 30, 2021 |
$ |
$ |
— |
$ |
||||||||
Forward Purchase Units |
||||
Fair value as of January 1, 2021 |
$ | |||
Initial measurement on January 26, 2021 |
||||
Change in fair value |
( |
) | ||
|
|
|||
Fair value as of June 30, 2021 |
$ | |||
|
|
Item 2. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
Item 3. |
Quantitative and Qualitative Disclosures About Market Risk |
Item 4. |
Controls and Procedures |
Item 1. |
Legal Proceedings |
Item 1A. |
Risk Factors |
Item 2. |
Unregistered Sales of Equity Securities and Use of Proceeds. |
No. |
Description of Exhibit | |
31.1* | Certification of Principal Executive Officer and Principal Financial and Accounting Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
32.1** | Certification of Principal Executive Officer and Principal Financial and Accounting Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
101.INS* | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | |
101.SCH* | Inline XBRL Taxonomy Extension Schema Document | |
101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase Document | |
101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase Document | |
101.LAB* | Inline XBRL Taxonomy Extension Labels Linkbase Document | |
101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |
104* | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
* | Filed herewith. |
** | Furnished herewith. |
PRIMAVERA CAPITAL ACQUISITION CORPORATION | ||||||
Date: August 16, 2021 | By: | /s/ Tong Chen | ||||
Name: | Tong Chen | |||||
Title: | Chief Executive Officer and Chief Financial Officer | |||||
(Principal Executive Officer and Principal Financial and Accounting Officer) |